"Viral Plaque Assay" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Method for measuring viral infectivity and multiplication in CULTURED CELLS. Clear lysed areas or plaques develop as the VIRAL PARTICLES are released from the infected cells during incubation. With some VIRUSES, the cells are killed by a cytopathic effect; with others, the infected cells are not killed but can be detected by their hemadsorptive ability. Sometimes the plaque cells contain VIRAL ANTIGENS which can be measured by IMMUNOFLUORESCENCE.
Descriptor ID |
D010948
|
MeSH Number(s) |
E01.370.225.875.970.790 E05.200.875.970.790
|
Concept/Terms |
Viral Plaque Assay- Viral Plaque Assay
- Assay, Viral Plaque
- Assays, Viral Plaque
- Plaque Assay, Viral
- Plaque Assays, Viral
- Viral Plaque Assays
Bacteriophage Plaque Assay- Bacteriophage Plaque Assay
- Assay, Bacteriophage Plaque
- Assays, Bacteriophage Plaque
- Bacteriophage Plaque Assays
- Plaque Assay, Bacteriophage
- Plaque Assays, Bacteriophage
|
Below are MeSH descriptors whose meaning is more general than "Viral Plaque Assay".
Below are MeSH descriptors whose meaning is more specific than "Viral Plaque Assay".
This graph shows the total number of publications written about "Viral Plaque Assay" by people in this website by year, and whether "Viral Plaque Assay" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2005 | 0 | 3 | 3 |
2006 | 0 | 1 | 1 |
2008 | 1 | 1 | 2 |
2011 | 0 | 1 | 1 |
2012 | 0 | 3 | 3 |
2013 | 0 | 1 | 1 |
2017 | 0 | 9 | 9 |
2018 | 3 | 8 | 11 |
2019 | 1 | 2 | 3 |
2020 | 1 | 10 | 11 |
2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Viral Plaque Assay" by people in Profiles.
-
A tissue culture infectious dose-derived protocol for testing of SARS-CoV-2 neutralization of serum antibodies on adherent cells. STAR Protoc. 2021 12 17; 2(4):100824.
-
Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus. Viruses. 2021 08 23; 13(8).
-
Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve In Vitro to Higher Infectivity through More Efficient Binding to Heparan Sulfate and Reduced S1/S2 Cleavage. J Virol. 2021 10 13; 95(21):e0135721.
-
Infectivity assay for detection of SARS-CoV-2 in samples from patients with COVID-19. J Med Virol. 2021 10; 93(10):5917-5923.
-
The next-generation coronavirus diagnostic techniques with particular emphasis on the SARS-CoV-2. J Med Virol. 2021 07; 93(7):4219-4241.
-
Peptide substrate screening for the diagnosis of SARS-CoV-2 using fluorescence resonance energy transfer (FRET) assay. Mikrochim Acta. 2021 03 25; 188(4):137.
-
Isolation and genetic characterization of SARS-CoV-2 from Indian patients in a single family without H/O travel abroad. Virus Genes. 2021 Jun; 57(3):245-249.
-
Sub-second heat inactivation of coronavirus using a betacoronavirus model. Biotechnol Bioeng. 2021 05; 118(5):2067-2075.
-
Survival of the enveloped bacteriophage Phi6 (a surrogate for SARS-CoV-2) in evaporated saliva microdroplets deposited on glass surfaces. Sci Rep. 2020 12 29; 10(1):22419.
-
Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Diagn Microbiol Infect Dis. 2021 Apr; 99(4):115294.